Research Article

Xyloglucan Based In Situ Gel of Lidocaine HCl for the Treatment of Periodontosis

Table 3

Formulation table.

Formulation codeClaritypHViscosity (cps) (±SD)Drug content (%) (±SD)Gelation temperature (°C) (±SD)
At 25°CAt 35°C

F1Transparent6.6233.66 ± 0.57445.66 ± 6.0296.5 ± 0.837.66 ± 0.3
F2Transparent6.81422.66 ± 3.51634.67 ± 4.1697.1035.33
F3Transparent6.7245.0 ± 1315.33 ± 3.0595.2036.66
F4Transparent6.62760.33 ± 2.512957.0 ± 5.6793.3020.33
F5Transparent6.52438.0 ± 8.542781.66 ± 4.0494.6021.33
F6Transparent6.8934.66 ± 2.081322.33 ± 2.5197.8035.66
F7Transparent6.81211.0 ± 10.141636.0 ± 5.2998.1035.33
F8Transparent6.62057.33 ± 5.032619.33 ± 6.1194.9522.66
F9Transparent6.7249.66 ± 222.51363.67 ± 3.5196.2037.66

±SD: Standard Deviation.